Cargando…
Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma
PURPOSE: Cachexia influences the patient’s physical wellbeing and quality of life, and the patient’s ability to tolerate their cancer therapies, especially cytotoxic chemotherapy. The purpose of this study was to investigate the frequency and timing of onset of cancer cachexia during chemotherapy an...
Autores principales: | Mitsunaga, Shuichi, Kasamatsu, Eiji, Machii, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546994/ https://www.ncbi.nlm.nih.gov/pubmed/32103356 http://dx.doi.org/10.1007/s00520-020-05346-8 |
Ejemplares similares
-
A Retrospective Cohort Study to Investigate the Incidence of Cachexia During Chemotherapy in Patients with Colorectal Cancer
por: Shibata, Masayuki, et al.
Publicado: (2020) -
A retrospective cohort study to investigate the incidence of cancer-related weight loss during chemotherapy in gastric cancer patients
por: Fukahori, Masaru, et al.
Publicado: (2020) -
Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
por: Shimagaki, Tomonari, et al.
Publicado: (2023) -
Review of the endocrine organ–like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma
por: Yu, Ying-Chun, et al.
Publicado: (2022) -
Pancreatic Ductal Adenocarcinoma Highly Expresses Activin A: Implications in Adipose Tissue and Cancer Cachexia
por: Xu, Pauline, et al.
Publicado: (2021)